Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.61 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.46 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31425839 | 0.90 | ANPEP (0.58) | ANPEPRIPK1KMT2AALDH1A1NPC1 | |
| SCHEMBL2910972 | 0.87 | RIPK1 (0.56) | ANPEPRIPK1KMT2AALDH1A1NPC1 | |
| SCHEMBL2749015 | 0.83 | RIPK1 (0.52) | ANPEPRIPK1KMT2AALDH1A1NPC1 | |
| SCHEMBL30878491 | 0.83 | TAAR1 (0.56) | ANPEPRIPK1KMT2ACYP2D6CYP2C9 | |
| SCHEMBL1397074 | 0.82 | RIPK1 (0.55) | ANPEPRIPK1KMT2AALDH1A1NPC1 | |
| SCHEMBL102342 | 0.81 | RIPK1 (0.61) | ANPEPRIPK1KMT2AALDH1A1NPC1 | |
| SCHEMBL18251689 | 0.80 | ERCC1 (0.56) | KMT2AALDH1A1MAPTCYP2D6CYP2C9 | |
| SCHEMBL12757441 | 0.80 | LMNA (0.63) | KMT2AALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL2456852 | 0.79 | KMT2A (0.58) | ANPEPRIPK1KMT2AALDH1A1NPC1 | |
| Hydrochloric Acid SCHEMBL20569216 | 0.79 | ANPEP (0.48) | ANPEPRIPK1KMT2AALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1586552-B1 | PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE | IHARA CHEMICAL IND CO (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-7326813-B2 | Process for producing benzylamine derivative | IHARA CHEMICAL INDUSTRY (JP) | 2008-02-05 | — | — | US | disclosed |
| US-20060155141-A1 | Process for producing benzylamine derivative | ITO AKINORI | 2006-07-13 | — | — | US | disclosed |
| EP-1586552-A1 | PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2005-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060155141-A1 | Process for producing benzylamine derivative | BRD7, BRD1, BRD2 | ANPEP 1249/4885RIPK1 4019/4885KMT2A 404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.